Cargando…
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
BACKGROUND: Antiangiogenic therapy has increasingly become an important strategy for the treatment of colorectal cancer. Recent studies have shown that the tumour microenvironment (TME) promotes tumour angiogenesis. Bufalin is an active antitumour compound whose efficacy has been indicated by previo...
Autores principales: | Fang, Kai, Zhan, Yueping, Zhu, Ruiqiu, Wang, Yuqian, Wu, Chengqi, Sun, Min, Qiu, Yanyan, Yuan, Zeting, Liang, Xin, Yin, Peihao, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424978/ https://www.ncbi.nlm.nih.gov/pubmed/34496870 http://dx.doi.org/10.1186/s12967-021-03058-z |
Ejemplares similares
-
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
por: Zhan, Yueping, et al.
Publicado: (2020) -
Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
por: Sun, Jian, et al.
Publicado: (2017) -
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
por: Yuan, Zeting, et al.
Publicado: (2018) -
Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity
por: Yin, Peihao, et al.
Publicado: (2012) -
Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway
por: Ju, Qianqian, et al.
Publicado: (2023)